FR2287228A1 - Nouveaux composes chimiques utiles en therapeutique humaine - Google Patents

Nouveaux composes chimiques utiles en therapeutique humaine

Info

Publication number
FR2287228A1
FR2287228A1 FR7531221A FR7531221A FR2287228A1 FR 2287228 A1 FR2287228 A1 FR 2287228A1 FR 7531221 A FR7531221 A FR 7531221A FR 7531221 A FR7531221 A FR 7531221A FR 2287228 A1 FR2287228 A1 FR 2287228A1
Authority
FR
France
Prior art keywords
alkyl
chemical compounds
compounds useful
new chemical
human therapeutics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7531221A
Other languages
English (en)
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Yoshitomi Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yoshitomi Pharmaceutical Industries Ltd filed Critical Yoshitomi Pharmaceutical Industries Ltd
Publication of FR2287228A1 publication Critical patent/FR2287228A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7531221A 1974-10-12 1975-10-13 Nouveaux composes chimiques utiles en therapeutique humaine Withdrawn FR2287228A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP49117503A JPS5152176A (2) 1974-10-12 1974-10-12

Publications (1)

Publication Number Publication Date
FR2287228A1 true FR2287228A1 (fr) 1976-05-07

Family

ID=14713345

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7531221A Withdrawn FR2287228A1 (fr) 1974-10-12 1975-10-13 Nouveaux composes chimiques utiles en therapeutique humaine

Country Status (7)

Country Link
JP (1) JPS5152176A (2)
AU (1) AU8564375A (2)
BE (1) BE834247A (2)
DE (1) DE2545501A1 (2)
FR (1) FR2287228A1 (2)
NL (1) NL7511857A (2)
SE (1) SE7511408L (2)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
EP0035374A3 (en) * 1980-03-01 1981-11-11 John Wyeth & Brother Limited Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203988A (en) 1975-11-12 1980-05-20 Merck & Co., Inc. Pyridinyl ureas and pharmaceutical use
US4806552A (en) * 1980-03-01 1989-02-21 John Wyeth & Brother, Limited Pyridyl- and/or pyridoyl-(piperid-4-yl) ureas and analogues thereof
US4722930A (en) * 1980-03-01 1988-02-02 John Wyeth And Brother Limited 3-benzoyl-1-[(oxo or thioheteroaryl-ylalkyl)-piperid-4-yl]ureas and derivatives
FI95572C (fi) * 1987-06-22 1996-02-26 Eisai Co Ltd Menetelmä lääkeaineena käyttökelpoisen piperidiinijohdannaisten tai sen farmaseuttisen suolan valmistamiseksi
AUPP818099A0 (en) 1999-01-14 1999-02-11 Fujisawa Pharmaceutical Co., Ltd. New n-containing heterocyclic compounds
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
AU2001238690A1 (en) 2000-03-14 2001-09-24 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
PT1587789E (pt) 2003-01-16 2008-12-16 Acadia Pharm Inc Agonistas inversos selectivos para receptores 2a/2c da serotonina como agentes terapêuticos para doenças neurodegenerativas
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
HRP20130713T1 (en) 2007-03-19 2013-09-30 Acadia Pharmaceuticals Inc. Combinations of 5-ht2a inverse agonists and antagonists with antipsychotics
PL3325444T3 (pl) 2015-07-20 2021-12-06 Acadia Pharmaceuticals Inc. Sposoby wytwarzania N-(4-fluorobenzylo)-N-(1-metylopiperydyn-4-ylo)-N'-(4-(2-metylopropyloksy)fenylometylo)karbamidu oraz jego soli winianowej i postaci polimorficznej C
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
EP3558311A1 (en) 2016-12-20 2019-10-30 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of alzheimer's disease psychosis
WO2018200977A1 (en) 2017-04-28 2018-11-01 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
WO2019046167A1 (en) 2017-08-30 2019-03-07 Acadia Pharmaceuticals Inc. PIMAVANSERIN FORMULATIONS
WO2024067304A1 (zh) * 2022-09-28 2024-04-04 瀚远医药有限公司 一种具有Sigma2和5HT2A抑制活性的化合物及用途

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387955A1 (fr) * 1977-04-22 1978-11-17 Beecham Group Ltd Derives de l'aniline utilisables comme medicament
EP0035374A3 (en) * 1980-03-01 1981-11-11 John Wyeth & Brother Limited Piperidyl - urea, - thiourea and - guanidine derivatives, and intermediates therefor, processes for preparing them and pharmaceutical compositions containing the derivatives

Also Published As

Publication number Publication date
JPS5152176A (2) 1976-05-08
BE834247A (fr) 1976-02-02
NL7511857A (nl) 1976-04-14
DE2545501A1 (de) 1976-04-22
AU8564375A (en) 1977-04-21
SE7511408L (sv) 1976-04-13

Similar Documents

Publication Publication Date Title
FR2287228A1 (fr) Nouveaux composes chimiques utiles en therapeutique humaine
ES462062A1 (es) Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinoleina.
ES449191A1 (es) Un procedimiento de preparacion de derivados de 4,5,6,7-te- trahidro-tieno-(2,3-c)-piridina.
DE3775319D1 (de) Imidazolylguanidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
AU6802490A (en) Novel 2-substituted 4-(3-alkyl-5-tert.-butyl-4-hydroxyphenyl)thiazoles, processes for their preparation, pharmaceuticals containing them and their use
ES434976A1 (es) Un procedimiento para la preparacion de un medicamento an- tibiotico.
FR2024548A1 (en) Ortho-substd phenethylamines and medicaments
FR2340947A1 (fr) Nouveaux derives de la tetrahydro-equinocandine b, leur preparation et leur application comme medicaments
GB1397624A (en) Composition ror oral administration for counteracting the greasy appearance of the head of hair and or the skin
FR2258840A1 (en) (4-Phenylpiperazino) alkyl esters - with analgesic activity for human and veterinary use
FR2555576B1 (fr) Derives de n-(methoxyphenacyl)-amine, utilisation notamment en therapeutique et procede de preparation
AR211118A1 (es) Metodo para producir compuestos de eteres de o-(2-aminoetil)-n-alquil (c4-c5) -sustituido-p-halofenilcetoxima.
ES442696A1 (es) Procedimiento para la obtencion de 2-amino-4 h-piranos.
ES461983A1 (es) Un procedimiento para la preparacion de nuevas cefalospori- nas.
NO308132B1 (no) Nye tetracykliske 1,4-oksazinforbindelser og farmasøytiske sammensetninger innholdende dem
FR2166101A1 (en) 1,4-di (morpholino,piperidino or pyrrolidino)-7-substd - -pyrido (3,4-d)-pyridazines - as diuretics
ES419386A1 (es) Un procedimiento para la preparacion de nuevos derivados deindenopirrol.
ES420718A1 (es) Procedimiento para la obtencion de dibenzazecinas.
FR2196813A1 (en) Substd hydroxy guanidines - as anti depressants
ATA501280A (de) Verfahren zur herstellung neuer 1,2,4-oxadiazin -derivate sowie von deren salze
ES397228A1 (es) Un metodo para producir nuevos compuestos de 1,2-metileno -17 alfa - aciloxi (o hidroxi mejorados) - 9 beta, 10 alfa- esteroides de la serie del pregnano.
ES391306A1 (es) Un procedimiento para producir una preparacion oral.
BE803955A (en) Substd hydroxy guanidines - as anti depressants
FR2290901A1 (fr) Nouveaux derives de l'imidazo(2,1-a)isoquinoleine, leur preparation et leur application comme medicaments
ES313451A1 (es) Un procedimiento para la preparacion de derivados de piridina.

Legal Events

Date Code Title Description
ST Notification of lapse